chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Numbness: Immediately with shot got a tingle down left arm (injection site)  and slight numbness in pinky and ring finger. Called advice nurse after numbness (no weakness) continued to be felt 5 hrs. later in pinky, ring and other left hand fingers.. 24 hrs later still feeling numbness in left pinky and ring finger only.   Swelling: (not itchy/ no pain/ just raised swelling) 10 hrs. after vaccine shot noticed a small round raised swelling under right eye. Under left eye a raised swelling occurred that was about one inch. Experienced chills through the night with nerve sensitivity in the mouth area. In the morning noticed small bumps/ swellings inside bottom lip of mouth and on tongue. Also a small swelling on left hand that looked like a raised round bump. Mouth: Took 5 mg Zyrtec in the morning which removed most of bumps inside lip and all of bumps on tongue. A feeling of swelling inside lip area remains 5 hours after taking Zyrtec.  Face: swellings under left eye 90% reduced 12 hrs after first noticing / 5 hrs after taking Zyrtec.  swelling under right eye 40% reduced 12 hrs after first noticing / 5 hrs after taking Zyrtec Hand:  swelling 90% reduced after first noticing 5 hrs ago / 5 hrs after taking Zyrtec.
11/19/14 patient's arm swelled the night of injection. 11/20/14 went to urgent care and diagnosed w/ cellulitis received antibiotics. 11/21/14 no improvement went to hospital for IV antibiotics.
At 14:32, client was referred over from post care station following H1N1 mist vaccination at 14:09. Client reported HA and nausea after mist administration. Assessment findings: Skin warm and dry to touch. No signs of rash on torso. Vitals WDL. At 14:46. patient reports no dizziness; c/o nausea. Client requested discharge home. Client's husband states he will drive client home. Both client and husband verbalize understanding of symptoms to watch for. Client has no difficulty breathing or swallowing. Client discharged.
her arm blew up; redness at injection site/ below the injection site; tingles arm; the nerves of her arm were irritated; arm still hurts; Labelled drug-drug interaction medication error; Allergic reaction; flu-like symptoms; sick for 3 days/ she still felt cruddy; fever; chills; achiness; exhaustion; nausea; This case was reported by a consumer via call center representative and described the occurrence of allergic reaction in a adult female patient who received Flu Seasonal QIV Quebec (FluLaval Tetra 2019-2020 season) for prophylaxis.   Co-suspect products included PNEUMOCOCCAL VACCINE POLYSACCHARIDE 23 VALENT (PNEUMOVAX 23) for prophylaxis.   On 24th September 2019, the patient received FluLaval Tetra 2019-2020 season (intramuscular) and PNEUMOVAX 23. In September 2019, less than a week after receiving FluLaval Tetra 2019-2020 season, the patient experienced sickness, chills, pain, exhaustion and nausea. On 26th September 2019, the patient experienced allergic reaction, influenza-like symptoms and fever. On an unknown date, the patient experienced swelling arm, erythema, tingling, neuralgia, pain in arm and labeled drug-drug interaction medication error. On an unknown date, the outcome of the allergic reaction and labeled drug-drug interaction medication error were unknown and the outcome of the influenza-like symptoms was resolved with sequelae and the outcome of the sickness, fever, chills, pain, exhaustion and nausea were recovered/resolved and the outcome of the swelling arm, erythema, tingling, neuralgia and pain in arm were not recovered/not resolved.   It was unknown if the reporter considered the allergic reaction, influenza-like symptoms, sickness, fever, chills, pain, exhaustion, nausea, swelling arm, erythema, tingling, neuralgia and pain in arm to be related to FluLaval Tetra 2019-2020 season.  Additional details were provided as follows: The patients birth date was reported as 16th July (no year reported). The patient was vaccinated with FluLaval Tetra and Pneumovax 23 on the same day in left deltoid, side by side, about 2 inches apart. The vaccine FluLaval Tetra was given by pre filled syringe intramuscularly. Post vaccination the patient was sick for 3 days. The patient elaborated the symptoms as fever, chills, achiness, exhaustion, and nausea. On 26th September 2019, the patient's fever broke but she felt cruddy for the next 3 days. Till the time of reporting the patient's arm was not right. The patient stated that her arm blew up, was red and it still tingles and hurted. The patient thought that maybe the nerves of her arm were irritated.  The patient said this occurred below the injection site. The patient wanted to know the ingredients in FLULAVAL Quadrivalent 2019-2020 Season because she feels that she may have had an allergic reaction to it or the Pneumovax 23. The reporter consented to follow up.
Patient called on 1/9/20 to let us know that his left arm had swollen to twice the normal size the following the vaccination. He had laid down to nap and slept with his left arm up on his left side and noticed it swollen. He was also dizzy and light headed. He took Tylenol that evening and visited 1/9/20 and we have an appointment with the office on 1/10/20. Per lady - patient prescribed Medrol Dosepak and Benadryl 25mg. Patient also reports had parasites on skin for 3 years.
Swollen injection site, aches, pains, chills, fever, sore throat. This continued until on the evening of 10/29 the patients fever increased and his oxygen level reduced. By the next day, 10/30, his oxygen level was below 90 and he was admitted to the hospital with pneumonia that the doctors have not yet been able to "Type" to provide correct treatment. Patient remains hospitalized and now cannot get oxygen level up to 90, even with oxygen administration.
This spontaneous report was received from a physician referring to a patient of unknown age and gender, The patient's pertinent medical history and concurrent conditions were not reported. On an unknown date, the patient was vaccinated with GARDASIL (anatomical route of vaccination, dose number, lot number and expiration date were not provided). The patient's concomitant medications were not reported. The physician stated that on an unknown date, the patient suffered from a "peculiar experience with GARDASIL". At the time of the report, the outcome of adverse event was unknown. The relatedness between the adverse event and vaccination with GARDASIL was not provided. Additional information has been requested.
Began sore, itchy throat. By the 2:00AM developed worsening sore throat, itchy throat, coughing, body aching, flu-like symptoms. Progressively got worse with same symptoms and fatigue and chest tightness, weakness. Notified the employee health nurse and was told she would document it in my medical records. This resulted in 3 missed work days.
This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a adult female patient who received SHINGRIX for prophylaxis. Concurrent medical conditions included paraplegia (Patient is a paraplegic and has neurological issues). On an unknown date, the patient received SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was unknown. It was unknown if the reporter considered the pain in arm to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The reporter spoke to a friend who received SHINGRIX vaccine and her arm killed her. The patient had denied permission to contact their physician. No additional details were available. This case is 1 of the 4 linked cases reported by the same reporter.
Pt describes feeling light headed and "floaty" approx 5 minutes post vax. Denies other SX. 1540 - BP - 128/90, P - 58, O2 sat 97% - provided water, rest 1555 - States sx resolved, BP - 130/84, P- 56, O2 sat 95% Pt leaves clinic.
Flu-like symptoms (soreness in muscles/joints, shaking/shivering). Shivering resolved within 2 hours after taking an Advil; continued minor muscle/joint soreness the following day (unmedicated).
My stomach had been hurting since I received this shot.  I am unable to eat because it makes my stomach hurt worse.
During injection my arm jumped and zinged, I got dizzy but it resolved quickly. Approximately 30 minutes later my arm began to ache. Every joint in my arm was aching. This continued through the night and into the next morning. Any movement hurts and if I lift my arm I feel the joint pain picking up again. I have received multiple flu shots and I have never had a reaction like this.
recently had titer testing / titers came back positive / Pharmacist definitely said "titers were positive"; received a 3 dose series of hepatitis B / (95, 29-june-95 and 9-feb-96) / received Engerix B / today; Drug dose administration interval too long; This case was reported by a pharmacist via call center representative and described the occurrence of hepatitis b positive in a 13-day-old female patient who received HBV (Engerix B) for prophylaxis.   Co-suspect products included Hepatitis B vaccine for prophylaxis, Hepatitis B vaccine for prophylaxis and Hepatitis B vaccine for prophylaxis.   On 8th July 2021, the patient received Engerix B. On 9th February 1996, the patient received the 3rd dose of Hepatitis B vaccine. On 29th June 1995, the patient received the 2nd dose of Hepatitis B vaccine. In 1995, the patient received the 1st dose of Hepatitis B vaccine. On 9th February 1996, not applicable after receiving Engerix B, Hepatitis B vaccine and Hepatitis B vaccine, unknown after receiving Hepatitis B vaccine, not applicable after receiving Engerix B, Hepatitis B vaccine and Hepatitis B vaccine and not applicable after receiving Engerix B, Hepatitis B vaccine and Hepatitis B vaccine, the patient experienced drug dose administration interval too long. On an unknown date, the patient experienced hepatitis b positive (serious criteria GSK medically significant) and extra dose administered. On an unknown date, the outcome of the hepatitis b positive, extra dose administered and drug dose administration interval too long were unknown.   It was unknown if the reporter considered the hepatitis b positive to be related to Hepatitis B vaccine, Hepatitis B vaccine and Hepatitis B vaccine.  Additional details were provided as follows: The pharmacist reported that the patient had received 3 dose series of Hepatitis B in 1995 to 1996 and now checked the titer which came positive for Hepatitis B. The patient 3rd dose longer than recommended interval, which led to lengthening of vaccine schedule. The patient received Engerix B on same day of reporting, which led to extra dose administered. The medical program director was requiring patient to be fully vaccinated by 4th October. Pharmacist was not sure of Hepatitis B brand administered but thought Recombivax, later it was determined during conversation with caller that it may not be Recombivax. The reporter consented to follow up.
I have a red rash under my breast area, on the side of my breast and right under my rib cage, navel and at shot sight.
SWOLLEN AREA BELOW THE SHOT/ SWELLING IN ARM; REDNESS IN PROXIMITY OF INJECTION SITE; SORE ARM; HEART FLUTTER; This spontaneous report received from a patient concerned a 68 year old White (Not Hispanic or Latino) female. The patient's height, and weight were not reported. The patient's past medical history included heart murmur, heart flutter, and severe hives with antibiotics, and concurrent conditions included non-alcoholic, non-smoker, sulfer allergy, and penicillin allergy, and other pre-existing medical conditions included the patient had no history of drug abuse or illicit drug use. The patient experienced drug allergy when treated with azithromycin, cefdinir, and ibuprofen. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: 206A21A, expiry: unknown) dose was not reported, 1 total administered on 30-APR-2021 on left arm as prophylactic vaccination. No concomitant medications were reported.  On 30-APR-2021, the patient experienced heart flutter. On 01-MAY-2021, the patient experienced sore arm. On 15-MAY-2021, the patient experienced swollen area below the shot/swelling in arm. On 15-MAY-2021, the patient experienced redness in proximity of injection site. The action taken with covid-19 vaccine was not applicable. The patient recovered from heart flutter on 30-APR-2021, and had not recovered from sore arm, swollen area below the shot/swelling in arm, and redness in proximity of injection site. This report was serious (Other Medically Important Condition).; Sender's Comments: Covid-19 vaccine heart flutter. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.
COVID-19; COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. An 80-year-old male patient received BNT162B2, BNT162B2 OMI BA.4-5, on 08Sep2022 at 11:00 AM as dose number unknown (booster), single (Lot number: GH9694), in left arm for covid-19 immunisation; COVID-19 VACCINE, as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "V Leiden blood clotting disorder" (unspecified if ongoing); "high blood pressure" (unspecified if ongoing); "overweight" (unspecified if ongoing). Concomitant medication(s) included: WARFARIN. Past drug history included: Morphine, reaction(s): "Known allergies- morphine"; Hydrocodone, reaction(s): "Known allergies- hydrocodone". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "recovering" and all described as "COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19. Additional information: Paxlovid treatment with start date on 28Nov2022 and treatment stop date on 03Dec2022, indication for treatment of COVID-19.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 57-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "asthma" (unspecified if ongoing); "mild hypothyroidism" (unspecified if ongoing), notes: mild hypothyroidism; "lichen sclerosis" (unspecified if ongoing), notes: lichen sclerosis; "known allergies: PCN" (unspecified if ongoing), notes: known allergies: PCN; "known allergies: molds" (unspecified if ongoing); "known allergies:dust" (unspecified if ongoing); "known allergies:pollen" (unspecified if ongoing); "known allergies:sulfites in food" (unspecified if ongoing), notes: known allergies: sulfites in food. The patient's concomitant medications were not reported. Past drug history included: E-mycin, reaction(s): "known allergies", notes: known allergies:E-MYCIN. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant) all with onset Jun2022, outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, suspected covid-19.  Additional information: Report about covid treatment reported as Yes. If vaccine received and Other medication in 2 weeks reported as unknown.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Fever over 104 degrees, runny nose, cranky, throwing up, rash at injection site, wouldn't stop crying. Went on for over a week.
It became difficult to breath and speak.; It became difficult to breath and speak.; This is a spontaneous report from a non-contactable consumer reported for herself that: A 36-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 03Apr2021 13:00 (Batch/Lot Number: ER8737) as DOSE 1, SINGLE for covid-19 immunization. The patient past Medical history included chronic sinusitis from an unknown date and unknown if ongoing, Known allergies: shellfish and ibuprofen. There were no concomitant medications.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccine within 4 weeks prior to covid-19 vaccination. The patient has not received other medications in two weeks. The patient experienced it became difficult to breath and speak on 03Apr2021 13:15. The patient is treated with Benadryl and Allergy tests- allergic vaccine. The events result in Doctor or other healthcare professional office/clinic visit. The event outcome was Unknown.  No follow-up attempts are Possible. No further information is expected.
Fatigue began around 1600. I woke up with severe nausea at 2300 that was accompanied by chills and uncontrollable shaking.  This lasted through the night until approximately 0500.
On 12/08/2022, I was standing for a rehearsal prior to giving a concert with a choral group, and experienced pain in my back and hips and could not complete the rehearsal. I started taking ibuprofen. I rested Monday and Tuesday. On Wednesday, I went to the family doctor, began physical therapy, x-rays are inconclusive, I have been on FLEXERIL, tramadol, AMBIEN. We are scheduling an MRI.
I developed what was thought to be pneumonia which was treated with an antibiotic and improved. About 10 days later I developed swelling in my right foot and calf.  A blood clot was suspected and I was sent to the hospital for and ultrasound which confirmed that I had a massive blood clot in my right leg from my groin to my ankle. I was advised to go to the emergency room, was admitted to the hospital,and a CAT scan taken of my lungs which showed that both of them had emboli. I was placed on a heparin drip for two days and now take blood thinner medication.
I had a mild case of COVID-19, I went to the doctor to get medication. I got over COVID-19, then I suddenly I started having extreme pain in areas of my body where I had, had previous injuries. I had used marijuana cream that gave me no relief. I made an appointment with my doctor who gave me pain medication that did help, but once I was out of the medication the pain returned much worse like I had been hurt by a large truck. I went back to the doctor, I was prescribed Tramadol, Meloxicam, Cymbalta that do help to give me relief. My hands, fingers swell, my arms ache all the way up into my neck. I will be going to the COVID-19 clinic to see if I can find out what is going on and hopefully get some relief.
Headache, swelling of hands  legs and feet. Rash on hands and face. Sore throat. Carpel tunnel flared up bad. Had 1st surgery already. Chills and fevers
about 12 hours later she woke up out of a sound sleep with her whole body shaking; Her heart was jumping out of her chest; she was very uncomfortable for 8-10 hours; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A 68 year-old female patient received bnt162b2 (BNT162B2), administration date Mar2021 (Batch/Lot number: unknown) as dose 2, single and administration date Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: TREMOR (non-serious) with onset Mar2021, outcome "unknown", described as "about 12 hours later she woke up out of a sound sleep with her whole body shaking"; PALPITATIONS (non-serious) with onset Mar2021, outcome "recovered", described as "Her heart was jumping out of her chest"; DISCOMFORT (non-serious) with onset Mar2021, outcome "recovered", described as "she was very uncomfortable for 8-10 hours". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Warm transfer from (name) with Support CEP159558. Caller is calling to ask about her nasty reaction to the COVID 19 vaccine. She is worried about it and it is not listed on the side effect sheet. She didn't specify what kind of reaction it was. The caller confirmed the details provided by the transferring agent. She got both of her first two shots three weeks apart in Mar2021. She would like to get the booster with Omicron and everything, but she had such a nasty reaction. She is worried about it. She has tried talking to her doctor and pharmacist, and no one will tell her anything. The pharmacist said to contact Pfizer directly. She is looking for information to see if anyone else has had this reaction. She has talked to dozens of people who have had all three shot with no issues. Caller declined email. She got her shot at 130 pm both times, and about 12 hours later she woke up out of a sound sleep with her whole body shaking. Her heart was jumping out of her chest, and she was very uncomfortable for 8-10 hours. It was worse with the second vaccine. Caller felt like the questions were to personal and declined to continue report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Extreme headache, overly tired, achy joints, dizziness, nausea---this continued through the night and into today.  Took Tylenol extra strength twice before headache finally subsided.  Slept until 4 p.m. today.  Was unable to focus or even think about going to work.  Last time I had the first shot in this series my arm hurt for 2 weeks afterwards and I had these same extreme side effects afterwards.
Blister at the injection site; Fever; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE VESICLES (Blister at the injection site) and PYREXIA (Fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE VESICLES (Blister at the injection site) and PYREXIA (Fever). At the time of the report, VACCINATION SITE VESICLES (Blister at the injection site) and PYREXIA (Fever) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.  No Concomitant medication were reported.  No treatment medication were reported.
Child received MMR and Influenza vaccine on 1/25/07. Developed seizures on 2/4/07 for which he was  hospitalized from 2/4/07 to 2/13/07. Regression of developmental occurred which are gradually returning with therapy.  07/17/2007 MR received for admission 2/23/2007.  Child presented with 10 day hx of fever with regression of developmental milestones. Pt had been hospitalized for new onset seizures 2/3/2007.